文献速递产科母胎医学

体外受精是胎盘植入谱系的独立危险因素

In vitro fertilization as an independent risk factor for placenta accreta spectrum.
PubMed 文献 · Am J Obstet Gynecol · 2020-04-30

该回顾性队列研究纳入2012-2019年单中心37461例分娩,分析体外受精与胎盘植入谱系的关系。多因素回归显示体外受精是独立危险因素(aOR 8.7,95%CI 3.8-20.3),调整既往剖宫产次数后仍显著(aOR 6.7,95%CI 2.9-15.6),但相对重要性低于前置胎盘和剖宫产史。

要点

  • 体外受精是胎盘植入谱系的独立危险因素,aOR 8.7(95%CI 3.8-20.3)。
  • 调整既往剖宫产次数后体外受精关联持续,aOR 6.7(95%CI 2.9-15.6)。
  • 前置胎盘和剖宫产史的相对临床重要性高于体外受精。

核心结论

  • 体外受精是胎盘植入谱系的独立危险因素,但其相对临床重要性相较于前置胎盘和剖宫产史较小。

研究设计与样本

  • 回顾性分析2012-2019年前瞻性人群队列中某三级学术中心的全部分娩,共37461例。

主要发现

  • 队列中5464例(15%)有剖宫产史,281例(0.7%)本次妊娠合并前置胎盘,571例(1.5%)为体外受精妊娠。
  • 胎盘植入谱系发生230例(0.6%)。
  • 多因素回归显示体外受精aOR 8.7(95%CI 3.8-20.3),既往剖宫产史aOR 21.1(95%CI 11.4-39.2),前置胎盘aOR 94.6(95%CI 29.3-305.1)。
  • 调整既往剖宫产次数后,体外受精aOR 6.7(95%CI 2.9-15.6)。

临床怎么用

  • 对体外受精妊娠应警惕胎盘植入谱系风险,尤其合并前置胎盘或剖宫产史时。
  • 产前评估需结合体外受精、前置胎盘及剖宫产史综合判断胎盘植入谱系风险。

局限性

  • 本研究为单中心回顾性分析,体外受精与胎盘植入谱系关联的病理生理机制尚待研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Placenta accreta spectrum is well known for its association with catastrophic maternal outcomes. However, its pathophysiology is not well defined. There have been emerging data that in vitro fertilization may be a risk factor for placenta accreta spectrum. OBJECTIVE: We investigated the hypothesis that in vitro fertilization is an independent risk factor for placenta accreta spectrum. STUDY DESIGN: A retrospective analysis of all deliveries in a prospective, population-based cohort (2012-2019) was performed in a tertiary academic center. Primary outcome variable was placenta accreta spectrum. Univariate analysis was performed on potential risk factors for predicting placenta accreta spectrum, and a multivariate model was designed to best fit the prediction of placenta accreta spectrum adjusted for risk factors such as cesarean delivery, placenta previa, age, and parity. History of previous cesarean delivery was known as a risk factor for both placenta previa and placenta accreta spectrum; hence, the interaction between "placenta previa" and "previous cesarean delivery" was included in the final model. Odds ratios were calculated as exponential of beta coefficients from the multivariate regression analysis. RESULTS: A total of 37,461 deliveries were included in this analysis, 5464 (15%) of which had a history of cesarean delivery, 281 (0.7%) had placenta previa in their index pregnancy, and 571 (1.5%) had in vitro fertilization pregnancy. The frequency of placenta accreta spectrum was 230 (0.6%). Independent risk factors for placenta accreta spectrum were in vitro fertilization pregnancy (adjusted odds ratio, 8.7; 95% confidence interval, 3.8-20.3), history of previous cesarean delivery (adjusted odds ratio, 21.1; 95% confidence interval, 11.4-39.2), and presence of placenta previa (adjusted odds ratio, 94.6; 95% confidence interval, 29.3-305.1). After adjustment for number of previous cesarean deliveries, the correlation persisted for in vitro fertilization (adjusted odds ratio, 6.7; 95% confidence interval, 2.9-15.6). CONCLUSION: Our data suggested that in vitro fertilization is an independent risk factor for placenta accreta spectrum, although its relative clinical importance compared with that of the presence of placenta previa and history of cesarean delivery is small. The pathophysiology behind this relationship remains to be investigated.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Salmanian B, Fox KA, Arian SE, et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol. 2020. PMID: 32360847. doi:10.1016/j.ajog.2020.04.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。